DVA News Alert Davita Healthcare Partners Inc (DVA) 73.10 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Davita Healthcare Partners Inc (DVA) 73.10 $DVA

Watch for DaVita to Potentially Rebound After Falling 4.31% Yesterday
Comtex SmarTrend(R) - Fri Feb 13, 3:46PM CST
DaVita (NYSE VA) traded in a range yesterday that spanned from a low of $71.89 to a high of $75.64. Yesterday, the shares fell 4.3%, which took the trading range below the 3-day low of $74.88 on volume of 6.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DVA: 73.10 (-3.29)

Today's Water-Logged And Getting Wetter Stock: DaVita HealthCare Partners (DVA)
at The Street - Fri Feb 13, 8:54AM CST
Trade-Ideas LLC identified DaVita HealthCare Partners (DVA) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
DVA: 73.10 (-3.29)

DaVita Beats on Q4 Earnings, Down Y/Y; Retains '15 View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 8:10AM CST
DaVita HealthCare Partners Inc. (DVA) reported fourth-quarter 2014 adjusted operating earnings of $1.09 per share that surpassed the Zacks Consensus Estimate of 88 cents.
ANTM: 141.05 (-0.95), DVA: 73.10 (-3.29), MOH: 59.66 (+0.26), HUM: 152.67 (-1.06)

DaVita HealthCare Partners updates guidance after Q4 results
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 7:18AM CST

DVA: 73.10 (-3.29)

DaVita HealthCare Partners (DVA) Earnings Report: Q4 2014 Conference Call Transcript
at The Street - Fri Feb 13, 3:24AM CST
The following DaVita HealthCare Partners (DVA) conference call took place on February 12, 2015, 05:00 PM ET. This is a transcript of that earnings call:
DVA: 73.10 (-3.29)

DaVita HealthCare Partners (DVA) Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 12, 7:40PM CST

DVA: 73.10 (-3.29)

DaVita HealthCare Partners (DVA) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Feb 12, 3:55PM CST

DVA: 73.10 (-3.29)

DaVita receives subpoenas from HHS
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 3:33PM CST

DVA: 73.10 (-3.29)

DaVita HealthCare Partners beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 3:06PM CST

DVA: 73.10 (-3.29)

DaVita HealthCare Partners Inc. 4th Quarter 2014 Results
PR Newswire - Thu Feb 12, 3:01PM CST
DaVita HealthCare Partners Inc. (NYSE: DVA) today announced results for the quarter and year ended December 31, 2014. Income from continuing operations attributable to DaVita HealthCare Partners Inc. for the quarter and year ended December 31, 2014 was $208 million and $723 million, or $0.96 and $3.33 per share, respectively. Adjusted income from continuing operations attributable to DaVita HealthCare Partners Inc. for the year ended December 31, 2014, excluding a loss contingency reserve and debt refinancing charges, was $792 million, or $3.64 per share.
DVA: 73.10 (-3.29)

Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 4:35PM CST

TNGO: 12.11 (+0.42), ELLI: 50.06 (+2.67), WWWW: 16.59 (+0.64), CYBR: 52.52 (+6.83), JCOM: 65.83 (+6.29), DLR: 68.65 (-2.07), SFLY: 44.86 (-2.13), KRFT: 64.42 (-1.75), NR: 9.85 (+1.07), CGNX: 41.82 (+0.95), MTSN: 4.04 (+0.19), WAGE: 62.17 (+3.72), RGC: 23.23 (+1.35), VCRA: 9.86 (+0.68), ALNY: 95.54 (+1.67), AIZ: 61.44 (-4.98), AEL: 29.15 (+0.66), EGN: 69.90 (+3.59), INT: 53.72 (+2.28), LBTYA: 52.49 (+2.70), LOGM: 52.22 (+4.17), CUZ: 11.26 (+0.25), PRO: 23.01 (-0.85), ZNGA: 2.24 (-0.42), BCOR: 14.20 (-0.45), GRPN: 7.97 (+0.51), KING: 16.70 (+1.96), SSNC: 63.38 (+1.40), PFIE: 2.60 (-0.06), KN: 18.59 (-3.05), COLM: 51.50 (+7.91), RSG: 39.34 (-1.67), SSTK: 56.49 (-2.75), TCO: 74.67 (-5.21), INWK: 6.29 (+0.69), MGI: 8.61 (-0.83), DVA: 73.10 (-3.29), IRWD: 15.15 (-0.85), BYD: 14.36 (-0.23), QLIK: 31.17 (+1.09), MOBL: 9.53 (-0.21), RBCN: 4.53 (-0.13), AIG: 53.96 (+1.51), CBS: 59.83 (+2.06)

DaVita HealthCare Partners Ranked 38th Among 2015 Training Top 125
PR Newswire - Wed Feb 11, 5:24AM CST
DaVita HealthCare Partners Inc. (NYSE: DVA), one of the nation's largest and most innovative health care communities, today announced that the company ranked 38th on Training magazine's Top 125 list for offering exemplary employer-sponsored training and development programs.
DVA: 73.10 (-3.29)

DaVita Healthcare (DVA): What's in Store for Q4 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 2:30PM CST
DaVita Healthcare Partners Inc. (DVA) is set to report fourth-quarter and full-year 2014 earnings results on Feb 12, 2015.
ACT: 285.37 (+3.71), LPNT: 69.04 (-0.06), DVA: 73.10 (-3.29), ACOR: 36.14 (-0.51)

DaVita Kidney Care Leads in Immunizations for 2014-2015 Season
PR Newswire - Thu Feb 05, 5:12AM CST
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that the company is a leader in immunizations for kidney care providers and has exceeded its own previous immunization rates for both dialysis patients and teammates.
DVA: 73.10 (-3.29)

InsiderInsights.com Daily Round Up 2/2/15: ALNY, MRTX, ZSAN, RLI
InsiderInsights - at Seeking Alpha - Tue Feb 03, 9:27AM CST

EGLE: 9.98 (-0.02), CKX: 15.30 (+0.34), IP: 57.31 (+0.12), ZSAN: 11.00 (-0.01), FDO: 77.86 (+0.31), SHLD: 35.70 (+2.32), VEEV: 30.12 (+0.17), DVA: 73.10 (-3.29), RLI: 49.57 (+0.47), ALNY: 95.54 (+1.67), FN: 16.94 (+0.02), FFIV: 116.64 (+1.37), MRTX: 22.51 (-0.08), MSFT: 43.87 (+0.78), MA: 87.14 (-0.38)

Centura Health and DaVita HealthCare Partners Introduce FullWell
PR Newswire - Fri Jan 30, 7:00AM CST
Centura Health and DaVita HealthCare Partners (NYSE VA) today unveiled FullWell, the brand name of the two partners' recently announced joint venture, a company that aims to bring greater value to health care and lower costs for consumers in Colorado and Kansas.
DVA: 73.10 (-3.29)

DaVita Kidney Care Offers Recipes for Football Fans to Enjoy During the Big Game
PR Newswire - Thu Jan 29, 4:48AM CST
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced its recipe collection, "Game Day Favorites When You're on a Kidney Diet," which allows kidney patients to enjoy football-inspired dishes modified for their nutritional needs.
DVA: 73.10 (-3.29)

Humana, DaVita Collaborate to Form Humana Kidney Care - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 28, 3:50PM CST
Humana Inc. (HUM) is making headlines with its latest partnership with kidney care service provider, DaVita Healthcare Partners Inc. (DVA).
CNC: 118.18 (-0.01), ANTM: 141.05 (-0.95), DVA: 73.10 (-3.29), HUM: 152.67 (-1.06)

DaVita Kidney Care Re-Launches its Website as Mobile-Friendly
PR Newswire - Wed Jan 28, 5:24AM CST
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced the launch of the newest version of DaVita.com, now mobile-friendly.
DVA: 73.10 (-3.29)

DaVita HealthCare Partners' VillageHealth and Humana Team up to Create Humana Kidney Care
Business Wire - Tue Jan 27, 12:30PM CST
VillageHealth, the integrated kidney care division of DaVita HealthCare Partners Inc. (NYSE: DVA), and Humana Inc. (NYSE: HUM) announced today that they are joining forces to create a special needs plan (SNP) for Medicare beneficiaries with end stage renal disease (ESRD). The program, called Humana Kidney Care, will specifically target ESRD patients in Las Vegas.
DVA: 73.10 (-3.29), HUM: 152.67 (-1.06)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 9

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 12

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 19

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Topicus.com Inc. Reports Impressive Q3 Growth in Earnings

Updated Category News Views 392

Topicus.com Inc. Achieves Record Financial Results in Q3 2024 Today, Topicus.com Inc. (TSXV: TOI) has shared promising financial data for the third quarter of 2024, indicating a strong upward trajectory in both revenue and profits. This positive news reflects a robust business performance managed under the guidance of Constellation Software Inc. (TSX: CSU). All figures...

Continue Reading
Rumble Experiences Significant Stock Surge with Dr Disrespect Deal

Updated Category News Views 97

Rumble Stock Experiences Notable Increase Rumble has recently witnessed a remarkable surge in its shares, jumping by as much as 17%. This increase represents the most significant intraday rise seen since July, attributed to an exciting partnership with gaming sensation Dr Disrespect. Exclusive Streaming Agreement with Dr Disrespect Under the partnership, Dr Disrespect...

Continue Reading
Michelin's Recent Trading Insights and Share Buyback Strategy

Updated Category News Views 227

Understanding Michelin's Share Buyback Initiative Michelin, well-known for its premium tire products, has been actively engaging in share repurchase activities. This initiative is significant for any investor as it showcases the company's robust financial health and strategic approach to increasing shareholder value. By buying back its shares, Michelin signals confidence...

Continue Reading
Treasury Yields Remain Steady as Inflation Data Looms

Updated Category Economy Views 300

Treasury Yields Steady Ahead of Key Inflation Data Treasury rates are not changing much while the market waits for important inflation figures. Investor caution is high in the last week of June. They are delaying significant actions until the report on Friday. Slightly higher is the yield on the 10-year Treasury. Similar little gains are seen in the two-year yield. The...

Continue Reading
MDPI Set to Transform Peer Review with Innovative Technology

Updated Category News Views 146

MDPI's Innovations in Peer Review MDPI, a leading open access (OA) publisher, is transforming the peer review process with new technology. This initiative ties in seamlessly with the upcoming Peer Review Week 2024, which focuses on 'Innovation and Technology in Peer Review'. Set to take place at the end of September, this event aims to showcase the evolving world of...

Continue Reading